The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice
about
Remyelination therapy for multiple sclerosisThe role of neurotrophins in multiple sclerosis-pathological and clinical implicationsNeurotrophins and Neuropathic Pain: Role in PathobiologyNeuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depressionGlatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of actionAmelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670 nm lightRegulation of learning and memory by meningeal immunity: a key role for IL-4Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination.Impact of acute inflammation on spinal motoneuron synaptic plasticity following ventral root avulsion.Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a.Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2Development of protective autoimmunity by immunization with a neural-derived peptide is ineffective in severe spinal cord injury.New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligandsGlatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell deathGlatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance.The double-edged sword of autoimmunity: lessons from multiple sclerosis.Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.Lithium enhanced cell proliferation and differentiation of mesenchymal stem cells to neural cells in rat spinal cord.Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.Disease Modifying Potential of Glatiramer Acetate in Huntington's DiseaseStepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine.The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone-induced death, through the NGF receptor TrkA.What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?FSD-C10: A more promising novel ROCK inhibitor than Fasudil for treatment of CNS autoimmunity.Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice.Interferon beta and glatiramer acetate therapy.Glatiramer acetate therapy for multiple sclerosis: a review.The role of dendritic cells in the generation of CD4(+) CD25(HI) Foxp3(+) T cells induced by amino acid copolymersDemyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitisEffect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factorsInhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitisGlatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate.
P2860
Q26824246-C56A4DF3-C5D9-484A-9CB8-C50860848D06Q26849274-0706E100-BE41-4906-8AE5-6D99B3DB4194Q28084413-E319AFA0-3EC5-4F7A-9BCC-D7776F2DA958Q28220405-C0979158-DFC2-4188-92CB-C59601BA5260Q28308287-126171B5-4D6A-4896-B8F6-B161693F7F02Q28732434-9B255348-D1D7-40CF-A846-E20789AD1E93Q30434189-847A62C4-8038-459F-B024-4AABDCF8B929Q33354106-C1E5605B-828F-44FB-B897-BB15DB9B89B2Q33558399-FD2091C3-B9A0-4BBE-97BD-187AD3FF2BDCQ33735502-EA8DB7E1-A9D7-4E7F-A8FD-453F152B1A40Q33868983-B6CC2DCC-68BC-4029-A8FC-B2C4C56035A4Q34055604-8CADB505-9155-431E-AAB7-F13AC036D7F2Q34098754-DE797116-7C2C-4DA0-984E-E36B35D5720CQ34143138-EA83BA6D-FEA7-4E8D-B6AA-2799876947FDQ34163814-F29C2124-5F8B-4090-9581-5C995AEA5046Q34317098-87BF3002-8CC4-4570-9EAA-F39DE1CE7F69Q34358322-082CB59B-4598-4B88-8393-A2341EB63551Q34771798-9B5062F3-7AFC-485A-9959-7DA193FFD0CFQ34976743-4D293E4F-8E64-4372-A2D3-F5DC4648CCC5Q35155753-EDDD766C-1CAE-463D-8376-0E39DB4E9FD0Q35276622-24C2A9FC-C697-4E71-9AD4-C6449A81F9A4Q35632053-4F76F043-3FAD-4B6A-978F-63772E8827ABQ35675328-BF88B77D-C527-4CCC-9BCB-928B33D87FB6Q35782283-08562304-298A-4ADB-89F8-2D5B1700A643Q35902446-C923B502-1F59-4C31-B21E-F262148CA4F7Q36253636-5514D2FB-BDFD-43B1-9A2B-98EBE23FF2AAQ36388390-D1E698AC-E87D-4F40-9C37-0AD3000CEE74Q36396476-D1A88860-424B-41C6-BF46-F6391ACA40DCQ36487022-6ABAC138-BBA7-40EB-B041-D2F32ED26A64Q36516097-142EA67C-CBF0-46E0-A362-24BCB91EEFEAQ36568660-66719AA2-325B-45EE-B27F-84D60F805DE5Q36662903-A68E456A-93FD-4B85-AE33-A8C988620696Q36749505-305CED2C-3273-4F73-AFA1-AD11598170BFQ36837427-5165AD70-74B4-457D-8EBF-28D463FC8329Q36869401-213BB02C-DA35-4490-949E-9CB4F4A1E48BQ37161098-9270F1BE-99E0-4CBA-9648-D1CBBCCC33B2Q37252541-D794A015-212D-4E18-A567-9A73A42BB615Q37367956-E5C54C6C-2FA4-4690-B8B7-29B104DBF26BQ37373698-CB38EA88-F832-4FE0-B59D-D8827EB0755BQ37378494-7E66695D-E5F9-4243-8462-8BA2C777F761
P2860
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@ast
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@en
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@nl
type
label
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@ast
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@en
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@nl
prefLabel
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@ast
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@en
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@nl
P2093
P2860
P356
P1476
The immunomodulator glatiramer ...... oimmune encephalomyelitis mice
@en
P2093
Galya Labunskay
Hagit Domev
Michael Sela
Raya Eilam
P2860
P304
19045-19050
P356
10.1073/PNAS.0509438102
P407
P577
2005-12-19T00:00:00Z